GPFA
BLRX

Game Plan Financial Advisors’s BioLineRX BLRX Stock Holding History

Game Plan Financial Advisors’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-450
Closed -$37K – 107
2021
Q4 		$37K Sell
450
-175
-28% -$18.2K 0.02% 104
2021
Q3 		$69K Sell
625
-100
-14% -$11.9K 0.04% 100
2021
Q2 		$81K Buy
725
+75
+12% +$8.82K 0.05% 97
2021
Q1 		$74K Buy
+650
New +$78.2K 0.05% 95

Other funds holding BLRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Game Plan Financial Advisors's BLRX Position: Q1 2022 in Review

Game Plan Financial Advisors sold out of BioLineRX (BLRX) in Q1 2022, closing a stake of 450 shares — an estimated $37K sold.

Game Plan Financial Advisors first reported a position in BLRX in Q1 2021 and held it in 4 quarters. The position peaked at $81K in Q2 2021. 26 funds tracked by Wall St. Rank hold BLRX as of Q1 2022.

  • Game Plan Financial Advisors reported no remaining BioLineRX position as of Q1 2022 after selling out during the quarter.
  • Game Plan Financial Advisors sold 450 BioLineRX shares in Q1 2022, an estimated $37K.
  • Game Plan Financial Advisors first reported a position in BioLineRX in Q1 2021 and held it in 4 quarters.
  • Game Plan Financial Advisors's BioLineRX position peaked at $81K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held BioLineRX as of Q1 2022.

Based on Game Plan Financial Advisors's 13F filing for Q1 2022, filed 22 Apr 2022.